title: [Extracranial stereotaxic body irradiation: preliminary results and the Orleans hospital experience].
abstract: Extracranial stereotactic body irradiation (ESRT) provides an alternative treatment mode for patients with no other therapeutic solutions. It's based on previous intracranial stereotactic radiosurgery techniques. ESRT with dedicated systems including secure immobilization avoiding patient movement, accurate repositioning, and stereotactic registration of tumor targets and organs at risk (OAR) allows very high doses in few fractions on extra cranial locations. Standard linacs permit performing SBRT with specific immobilization devices including stereotactic location of the target. Different schemes of ESRT have been published. Comparison of these very diverse schemes is not easy since the prescription mode on target volumes and OAR are not always clearly defined. The Radiotherapy Department of Orléans Hospital chose to set up the ESRT on a conventional accelerator using an immobilization device including a Stereotactic Body Frame and an Active Breathing Control system (Elekta). From 120 patients treated with ESRT since 1999, 90 cases are presented; 28 lung metastases were treated with 40 Gy/5 fr/12 d and 17 liver metastases were treated with 30 Gy/5 fr/12 d prescribed on the 70 to 85 % isodose. The local control was obtained in 50 % of the cases. Twenty-eight patients were treated for T1-T2 N0 lung cancer with 50 Gy/10 fr/12 d on the 80 % isodose. Local control was obtained in 50 % of the cases. Seventeen liver cancers were treated with 30 Gy/10 fr/15 d prescribed on the 70 to 80 % isodose. Local control was obtained in 47 % of the cases. ECRT allows controlling localized tumors (primitives or metastases) and it is now a suitable part of our therapeutic tools as radiofrequency or cryotherapy techniques. Phase II studies are required to confirm its therapeutic potential.
authors.affiliation: Service de radiothérapie, Centre hospitalier régional, 14, avenue de l'Hôpital, 45100 Orléans, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Wachter
authors.forename: Hélène
authors.initials: H
authors.lastname: Bouscayrol
authors.forename: Elise
authors.initials: E
authors.lastname: Champeaux
authors.forename: Pierre
authors.initials: P
authors.lastname: Verrelle
authors.forename: Philippe
authors.initials: P
authors.lastname: Giraud
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000532:radiotherapy / Q000601:surgery; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary; D001984:Bronchial Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D005602:France; D006801:Humans; D007680:Kidney Neoplasms / Q000532:radiotherapy / Q000601:surgery; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000556:secondary / Q000601:surgery; D008175:Lung Neoplasms / Q000532:radiotherapy* / Q000556:secondary / Q000601:surgery; D055585:Physical Phenomena; D010825:Physics; D016634:Radiosurgery / Q000379:methods*; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation / Q000379:methods*